LRBA: A Possible Key Player in Cancer Cell Autophagy
Overview
Chemotherapy is frequently the only viable treatment for cancer patients. But tumor cells are capable of adapting and developing resistance to this treatment. Autophagy, the cell’s recycling process, is thought to be key in tumor cells’ ability to become chemoresistant. By studying how autophagy is regulated, specific proteins may be identified that can serve as potential therapeutic targets to override chemoresistance. Atg9, one core regulator of autophagy, was recently found to interact frequently with LRBA in a mass spectrometry analysis. LRBA is a novel regulator of human immune disorders, but little is known about it in the context of cancer cell autophagy. In my experiment, I aimed to identify whether LRBA plays a role in cancer cell autophagy by conducting a colocalization experiment of LRBA and Atg9. I found that the proteins strongly colocalized under basal conditions, thus possibly indicating LRBA as a key to autophagosomal vesicle trafficking. More research is being conducted, including a colocalization of LRBA with LC3 and Atg9 under nutrient-deprived conditions in order to gauge the impact of LRBA on autophagic activity.
Competition history
- ISEF 2017
Resources
Related projects
ISEF · 2023
Eliminating Drug Resistance of Lung Cancer Through Inducing Autophagy by Targeting USP24
ISEF · 2022
A Novel Autophagy-Related Gene Regulates Autophagy Through Endolysosomal Pathway
ISEF · 2014
Loss of TSC2 Signals for Altered Macrophage Function within Lymphangioleiomyomatosis: A Role for VEGF-D?
ISEF · 2018
The Role of NRBF2 in the Regulation of the ULK1 Kinase Complex
ISEF · 2024
Determination of Primary Retinoblastoma Extracellular Vesicle Uptake Pathway via Surface Protein Inhibitors
ISEF · 2015
Search for New Ways to Improve Immune Response against Cancer: Modulation of FASL (CD95L) by Lipid Mediators on Lymphocytes
ISEF · 2016
Nutrient Starvation-Induced Cancer Cell Death in Acute Myeloid Leukemia Cells
ISEF · 2022
Phase VII: Inhibiting Cancer Metastasis by Using EGCG To Target the 67 kDa Laminin Receptor
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair